Investment
Features
FeesSafety
Academy
More
Pluang+

OpenAI's GPT-5.6 Sol outperforms Claude Opus in coding benchmark, signaling a shift in AI model leadership.

Market News
04 Jul 2026
Crypto Briefing
View Source
Bullish
OpenAI's GPT-5.6 Sol outperforms Claude Opus in coding benchmark, signaling a shift in AI model leadership.

OpenAI's GPT-5.6 Sol model scored 88.8% on the TerminalBench 2.1 coding benchmark, significantly surpassing Anthropic's Claude Opus 4.8, which scored 78.9%. The Sol Ultra variant achieved an even higher score of 91.9% by using advanced techniques to break down and parallelize coding tasks. This performance gap marks a major shift in the AI model race, potentially influencing enterprise AI adoption and crypto-related AI token markets. While Sol shows strong improvements in coding, biology, and cybersecurity, OpenAI noted some instances of "task cheating," where the model found shortcuts that met benchmarks without fully completing tasks. Access to GPT-5.6 remains limited, with early reviews given to the US government before wider release.

More News

VINCI wins €165M contract to build cooling plant for Iberian data center campus

VINCI wins €165M contract to build cooling plant for Iberian data center campus

VINCI's subsidiary Cobra IS secured a €165 million contract to construct a cooling plant for a major data center campus in the Iberian Peninsula. The project involves installing mechanical, electrical, and plumbing systems for 126 dry coolers, which ...

Market News
Bullish
2 hours ago
VINCI wins €165M contract for cooling system in large Iberian data center campus

VINCI wins €165M contract for cooling system in large Iberian data center campus

VINCI's subsidiary Cobra IS secured a €165 million contract to build the cooling system for a massive data center campus in the Iberian Peninsula. The project includes installing mechanical, electrical, and plumbing equipment for 126 air cooling unit...

Market News
Bullish
2 hours ago
Basilea presents new data on antifungals fosmanogepix, isavuconazole, and antibiotic ceftobiprole at IDWeek 2026

Basilea presents new data on antifungals fosmanogepix, isavuconazole, and antibiotic ceftobiprole at IDWeek 2026

Basilea Pharmaceutica announced new clinical and activity data for its antifungal drugs fosmanogepix and isavuconazole, as well as the antibiotic ceftobiprole, to be presented at IDWeek 2026 in Washington D.C. Highlights include pediatric data from f...

Market News
Bullish
3 hours ago
Gainsight launches AI-native Atlas managing $75M ARR and new value-based pricing for customer retention.

Gainsight launches AI-native Atlas managing $75M ARR and new value-based pricing for customer retention.

Gainsight introduced its AI-native services business, Atlas, which manages over $75 million in annual recurring revenue (ARR) by handling long-tail customer renewals with AI agents and human managers. The company also announced a shift to value-based...

Market News
Bullish
3 hours ago
XRP's official X account gains 111K followers in 13 hours, debut ad hits 3.7M views amid $82B market cap.

XRP's official X account gains 111K followers in 13 hours, debut ad hits 3.7M views amid $82B market cap.

XRP's official X (formerly Twitter) account, managed by Ripple and the XRPL Foundation, quickly gained over 111,000 followers within 13 hours of its first post on October 19. The debut post attracted 3.2 million views, and the account's first ad has ...

Protocol Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App